Some new 6-(substituted phenyl)-2-(4-substituted phenyl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4,5-dihydropyridazin-3(2H)-one derivatives were synthesized by a sequence of reactions starting from respective aryl hydrocarbons. The final compounds (4a-i) were screened for antihypertensive activities by non-invasive method using Tail Cuff method. The compounds 4e and 4i showed appreciable antihypertensive activity.
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INTRODUCTION
Hypertension is the most common cardiovascular disease and is the major risk factor for coronary artery disease leading to myocardial infarction and sudden cardiac death, heart failure, stroke and renal failure 1 . Great efforts have been made on obtaining novel antihypertensive agents acting on different mechanisms to control blood pressure 2 . The studies on the hydralazine group drugs led to the synthesis of many pyridazine derivatives with a wide activity spectrum on cardiovascular system 3 . Pyridazine derivatives, a class of compounds containing the N-N bond, exhibit a wide range of pharmacological activities such as antidepressant 4 , antihypertensive [5] [6] [7] [8] , antithrombotic 9 , anticonvulsant 10 , cardiotonic 11 , antibacterial 12 , diuretics 13 , antiHIV 14 and anticancer 15 . Some pyridazinone derivatives like indolidan 16 , bemoradan 17 , primobendan 18 , levosimendan 19 (antihypertensive), already approved in the clinical market. The current work describes the synthesis of some new substituted pyridazine derivatives with encouraging antihypertensive activity by non-invasive method using Tail Cuff method.
EXPERIMENTAL
Melting points were determined by open tube capillary method and are uncorrected. Purity of the compounds was checked by thin layer chromatography (TLC) method. The FT-IR spectra were recorded on Biorad FTS-135 spectrophotometer using KBr pellets; υ max values are given in cm -1 . 1 H-NMR spectra were recorded on Bruker Spectrospin DPX 300 MHz using CDCl 3 as solvent and tetramethylsilane (TMS) as an internal standard. Chemical shifts are given in δ (ppm) scale and coupling constants (J values) are expressed in Hz. The FAB Mass spectra were obtained on JEOL-JMS-DX 303 system, equipped with direct inlet probe system. Elemental analysis was carried out on CHNS Elementar (Vario EL III) using sulphanilic acid as a standard and tugsten (VI) oxide as a combusting agent and analyses for C, H, and N were within ±0.4% of the theoretical values.
General procedure for the synthesis of β-aroylpropionic acids 1(a-c) To liquid aromatic hydrocarbon (30 mL), anhydrous aluminum chloride (16.6 g, 0.125 mol) was added. The mixture was stirred using a magnetic stirrer at room temperature for 30 min. To this, succinic anhydride (5 g, 0.05 mol) was added in five portions with continuous stirring. Vigorous reaction started with the evolution of HCl gas. Stirring was continued for another 6 h at room temperature. The mixture was left at room temperature for 48 h and then decomposed by adding ice-cold hydrochloric acid (50%, 100 mL). The excess solvent was removed by steam distillation. The precipitated solid was treated with saturated sodium bicarbonate solution, filtered, washed with cold water, dried, and crystallized from the appropriate solvent to give 1a-c 21, 22 . General procedure for the synthesis of 6-Oxo-3-substituted-phenyl-5,6-dihydropyridazine-1(4H)-carbohydrazide 2(a-c)
To a solution of substituted β-aroyl propionic acids (0.01 mol) in ethanol (30 mL) were added carbohydrazide (0.01 mol) and sodium acetate, and the mixture was refluxed for 6 h. After completion of the reaction, ethanol was distilled off and the residue was poured into cold water. The solid which separated was filtered and washed with water. The product was dried in air and crystallized from ethanol 23 . JAN-2000) , Jamia Hamdard and kept under standard laboratory conditions in 12 h light/dark cycle at 25 ºC ± 2 ºC. Animals were provided with pellet diet (Lipton, Calcutta, India) and water ad libitum. They were marked for easy identification.
6-(4-Methoxyphenyl)-2-[4-(4-bromophenyl)-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]-4,5-dihydropyridazin-3(2H)-one, 4h,

6-(4-Methoxyphenyl)-2-[4-(3-methylphenyl)-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl]-4,5-dihydropyridazin-3(2H)-one, 4i,
Conditioning/training of animals For conducting the BP measurement studies, the animals were kept in a restrainer for 10 min every day for one week. This exercise was done to avoid the fluctuation in blood pressure due to aggressive behavior of animal while keeping into the restrainer for measuring the activity.
Induction of hypertension in normotensive rats
After recording the initial BP of rats, the animals were divided into groups of 5 animals each. One group was taken as control. Hypertension was induced in the remaining groups by subcutaneous injection of methyl prednisolone acetate (20 mg/kg/wk) for 2 weeks as per method reported by Krakoff et al. 24 .
Measurement of mean blood pressure of rats
Mean arterial blood pressure was measured in conscious rats using CODA Non Invasive Blood Pressure Recorder by Tail-Cuff method (Kent Scientific Corporation, USA). The restrainer carrying the rat was placed in the BP instrument with tail protruding out. The tail was gently placed in contact with a transducer membrane, which was connected to the digital BP display panel. The instrument was then turned on and allowed to stabilize until steady pulse rate was observed. Once the ''pulse level ready'' signal appeared, the BP recording button was pressed and the mean arterial BP was recorded. Albino rats (body weight 200-250 g) were used in present study. Rats were assigned to groups of four animals in each. Each compound (20 mg/kg body weight) was injected intraperitoneally after suspending in 1% carboxymethyl cellulose (CMC) solution. The mean arterial blood pressure was recorded after 1 h.
Statistical analysis of data
The statistical analysis was performed using GRAPHPAD INSTAT 3 software (Graph Pad Software Inc, San Diego, CA). Data obtained from animal experiments were expressed as arithmetic mean ± SEM. The comparison between various groups was performed by one-way analysis of variance (ANOVA), and the effect in treatment groups were compared with toxic control group by Dunnet multiple comparison test. p < 0.05 was considered to be significant [*p < 0.05; **p < 0.01]. The percentage reduction in MABP for all the treatment groups was also calculated and compared.
RESULTS AND DISCUSSION
Chemistry
The synthesis of some new 1,2,4-triazole derivatives of 4,5-dihydro-3(2H)-pyridazinone has been carried out according to the steps shown in the Dose of Propranolol was taken as 14 mg/kg. b Dose of hydralazine was taken as 2.6 mg/kg. All values were expressed as Mean ±SEM (*p ≤ 0.05), each group comprised of four animals (i.e. n=4). Toxic control group was compared with control group. All the treatment groups were compared with toxic control group and p < 0.05 was considered to be significant. ** P < 0.01, * P < 0.05.
multiplets at δ 7.13-7.93 are indicative of aromatic protons. The singlet at δ 10.78 is due to CSNH group flanked by two nitrogen atoms. The structure is also supported by elemental analysis data and 13C NMR data. The other compounds are also identified in a similar manner. The mass spectrum shows the presence of peak at definite m/z value in accordance to the molecular formula. The elemental analysis results were within ±0.4% of the theoretical values.
Antihypertensive activity
The final compounds (4a-4i) were evaluated for antihypertensive activity by non-invasive method using Tail Cuff method. The results were shown in Table 1 and compared with standard drug, hydralazine 20 and propranolol. Compound 4e and 4i were found to show highly significant reduction in mean arterial blood pressure but at higher dose in comparison to standard drugs. The mechanism of action of pyridazine (similar to vasodilators) derivatives has been shown in Figure 2 . , or VEGF and NO, via the BK B2 receptor 26 . The BK B2 receptor can also activate the VEGF receptor on endothelial cells. ACE inhibition results in BK accumulation and promotion of neovascularization. Moreover, angiotensin II activates the AT2 receptor during AT1 receptor blockade, thereby upregulating BK and contributing to an angiogenic response 27 . ATR, angiotensin receptor.
CONCLUSIONS
Various 6-(substituted phenyl)-2-(4-substituted phenyl-5-thioxo-4,5-dihydro-1H-1,2,4-triazol-3-yl)-4,5-dihydropyridazin-3(2H)-one derivatives can be further modified to exhibit better potency than the standard drugs. Further studies to acquire more information about Quantitative Structure Activity Relationships (QSAR) are in progress in our laboratory. The substituted pyridazine derivatives discovered in this study may provide valuable therapeutic intervention for the treatment of hypertension.
